```html PetScript Pharmacy compounds pimobendan oral suspension — a calcium sensitizer and selective phosphodiesterase-3 inhibitor with positive inotropic and vasodilator effects — for veterinarians managing canine congestive heart failure secondary to myxomatous mitral valve disease or dilated cardiomyopathy. This precision liquid formulation supports accurate, titratable dosing for cardiology cases where commercial tablet strengths don't align with the calculated dose. Our pharmacy integrates seamlessly with veterinary e-prescribing NCPDP standards, enabling clinicians to transmit prescriptions electronically with the same security and efficiency used in human healthcare. For canine heart failure patients requiring lifelong therapy, customized compounding removes barriers like pill size, palatability, and dosing precision. As part of our comprehensive veterinary drug shortage compounding solutions, we ensure uninterrupted access to critical cardiac medications when your patients need them most. Understanding veterinary office stock compounding regulations is essential for maintaining compliant workflows while ensuring timely patient care. Partnering with a PCAB accredited veterinary compounding pharmacy supports continuity of care and long-term treatment success for your cardiology caseload. Learn more about navigating compliance in our guide: How State Pharmacy Board Office Stock Compounding Restrictions Are Reshaping Veterinary Practice Workflows. ```